Evoke Pharma Ownership | Who Owns Evoke Pharma?
Evoke Pharma Ownership Summary
Evoke Pharma is owned by 6.09% institutional investors, and 93.91% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.30% of its assets in Evoke Pharma shares.
EVOK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Evoke Pharma | 6.09% | - | 93.91% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 34.90% | 10.53% | 54.58% |
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | 18 | -21.74% | 1,997,549 | -2.46% | 6 | 15.05% | 7 | -12.50% | 5 | - |
| Dec 31, 2021 | 23 | 4.55% | 2,047,919 | -51.29% | 6 | 3.81% | 8 | - | 5 | - |
| Sep 30, 2021 | 22 | - | 4,204,343 | -6.66% | 12 | 6.68% | 8 | -20.00% | 5 | 66.67% |
| Jun 30, 2021 | 22 | -24.14% | 4,504,481 | 4.81% | 13 | 7.31% | 10 | -16.67% | 3 | -25.00% |
| Mar 31, 2021 | 29 | -9.38% | 4,297,637 | 66.20% | 13 | 13.41% | 12 | -20.00% | 4 | -33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Extended Market Index | 2.45K | 0.30% | -905.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.49K | 0.28% | - |
| Fidelity Nasdaq Composite Index | 373.00 | 0.05% | - |
| State Street Balanced Index K | 314.00 | 0.04% | - |
| Fidelity Series Total Market Index | 246.00 | 0.03% | - |
| NT Ext Equity Mkt Idx Fd - L | 168.00 | 0.02% | - |
| Northern Trust Extended Eq Market Idx | 168.00 | 0.02% | - |
| NT Ext Equity Mkt Idx Fd - NL | 101.00 | 0.01% | - |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 81.00 | 0.01% | - |
| Spartan Total Market Index Pool E | 70.00 | 0.01% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 14, 2020 | Gonyer David A | President and CEO | Sell | $70.42K |
| Dec 11, 2020 | Gonyer David A | President and CEO | Sell | $139.33K |
| Dec 10, 2020 | D'Onofrio Matthew J | Exec VP, Chief Bus. Officer | Sell | $16.65K |
| Dec 11, 2020 | D'Onofrio Matthew J | Exec VP, Chief Bus. Officer | Sell | $117.44K |
| Aug 20, 2018 | LVP GP III, LLC | - | Buy | $1.09M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2023 Q2 | - | - |
| 2023 Q1 | - | - |
EVOK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools